Columbus Macro’s VanEck Biotech ETF BBH Stock Holding History

Columbus Macro’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,606	Closed	-$423K	–	176
2022 Q1	$423K	Buy	2,606 +54	+2%	+$8.75K	0.14%	128
2021 Q4	$483K	Sell	2,552 -886	-26%	-$171K	0.16%	119
2021 Q3	$695K	Sell	3,438 -2,662	-44%	-$559K	0.23%	110
2021 Q2	$1.23M	Sell	6,100 -895	-13%	-$167K	0.38%	77
2021 Q1	$1.23M	Sell	6,995 -68	-1%	-$12.3K	0.38%	81
2020 Q4	$1.2M	Sell	7,063 -180	-2%	-$29.7K	0.37%	79
2020 Q3	$1.17M	Sell	7,243 -405	-5%	-$65.9K	0.36%	77
2020 Q2	$1.25M	Buy	7,648 +3,564	+87%	+$542K	0.34%	69
2020 Q1	$523K	Buy	+4,084	New	+$550K	0.15%	106

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Columbus Macro's BBH Position: Q2 2022 in Review

Columbus Macro sold out of VanEck Biotech ETF (BBH) in Q2 2022, closing a stake of 2,606 shares — an estimated $423K sold.

Columbus Macro first reported a position in BBH in Q1 2020 and held it in 9 quarters. The position peaked at $1.25M in Q2 2020. 108 funds tracked by Wall St. Rank hold BBH as of Q2 2022.

Columbus Macro reported no remaining VanEck Biotech ETF position as of Q2 2022 after selling out during the quarter.
Columbus Macro sold 2,606 VanEck Biotech ETF shares in Q2 2022, an estimated $423K.
Columbus Macro first reported a position in VanEck Biotech ETF in Q1 2020 and held it in 9 quarters.
Columbus Macro's VanEck Biotech ETF position peaked at $1.25M in Q2 2020.
108 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2022.

Based on Columbus Macro's 13F filing for Q2 2022, filed 27 Jul 2022.